Recruiting Temporal Lobe Epilepsy Studies in Birmingham
ABTECT - Maintenance
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy....
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma
The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This st...
Ribociclib (LEE011) Rollover Study for Continued Access
This study is to allow continued use of ribociclib (LEE011) as single agent or in combination with other investigational treatments in patients benefitting from treatment in an eligible Novartis-spons...
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
The main goals of this clinical study are to learn if AMT-260 is safe and tolerable and works to reduce the frequency of seizures in adults with unilateral mesial temporal lobe epilepsy (MTLE)....
About Temporal Lobe Epilepsy Clinical Trials in Birmingham
Temporal lobe epilepsy is the most common form of focal epilepsy, with seizures originating in the temporal lobe of the brain. It can cause unusual sensations, memory problems, and altered consciousness. Treatment includes antiseizure medications and surgery for drug-resistant cases.
There are currently 5 temporal lobe epilepsy clinical trials recruiting participants in Birmingham, ALABAMA. These studies are seeking a combined 1,802 participants. Research is being sponsored by Abivax S.A., Biohaven Therapeutics Ltd., BeiGene and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Temporal Lobe Epilepsy Clinical Trials in Birmingham — FAQ
Are there temporal lobe epilepsy clinical trials in Birmingham?
Yes, there are 5 temporal lobe epilepsy clinical trials currently recruiting in Birmingham, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What temporal lobe epilepsy treatments are being tested?
The 5 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for temporal lobe epilepsy.
Data updated March 2, 2026 from ClinicalTrials.gov